Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Treatments that help the immune system fight cancer have revolutionized cancer care.
Customized T-cell treatment is generally safe for people living with HIV, and outcomes are comparable to those of HIV-negative people.
However, lung cancer incidence among HIV-positive people has fallen over the past two decades.
Researchers looked both at the first and second time people with HIV have been diagnosed with cancer.
Early and sustained antiretroviral treatment could help reduce the risk.
An estimated 7,760 HIV-positive U.S. residents were diagnosed with cancer in 2010.
Declining rates are expected for Kaposi sarcoma, non–Hodgkin lymphoma, cervical and lung cancer and Hodgkin lymphoma, among others.
This held true in a recent study among those who were on treatment for the virus.
However, older people with HIV have a lower rate of a few other cancers compared with the general population.
However, compared with the general population, HIV-positive individuals remain at higher risk for a slew of malignancies.
With the HIV population aging, it is increasingly at risk of such age-related cancers.
A recent study found that from 1995 to 2009, 10 percent of all deaths among a large cohort of people on HIV treatment were cancer-related.
The increased risk of some virus-associated cancers, such as non–Hodgkin lymphoma, did not appear driven by increased sexual risk taking.
As AIDS-related cancers decline and the HIV population ages, the most common malignancies by 2030 will likely be those related to aging.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.